Lupin arm unveils heart drug in Canada
Montreal: Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited has announced the launch of Propranolol LA (long-acting) capsules, 60 mg, 80 mg, 120 mg and 160 mg, in Canada....
Stay updated with breaking news from Sofia Mumtaz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Montreal: Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited has announced the launch of Propranolol LA (long-acting) capsules, 60 mg, 80 mg, 120 mg and 160 mg, in Canada....
/PRNewswire/ -- Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited (Lupin), today announced the launch of Propranolol LA (long-acting)...
Mumbai: Global pharma major Lupin Limited has announced that its Canada subsidiary, Lupin Pharma Canada Ltd., has received approval from Health Canada to market a generic version of Spiriva...
Mumbai: Global pharma major, Lupin Limited, announced today that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in Canada.Rymti is indicated in the treatment of...
Lupin is dedicated to increasing patient access to high-quality, life-improving biosimilars.